Trends are like compasses in that they can show you where opportunity resides. And as every business is influenced by the latest trends, it pays for biopharmaceutical executives to pay attention. In preparing for this year’s annual outlook issue (published in December), Life Science Leader posed some trend-oriented questions to a group of biopharma execs, and here […]

In a year that began with so much promise on the COVID-19 front, we now face deadly familiar headlines and new threats such as the Omicron variant that has the world on alert. This latest blow comes amid alarming and widespread spikes in infections globally, a still pernicious Delta variant, and rapidly climbing numbers of […]

Cyclacel (Berkeley Heights, NJ) is a clinical-stage biopharmaceutical company developing innovative cancer medicines based on cell cycle, transcriptional regulation, and mitosis biology. Its aim is to build a diversified biopharma business based on a pipeline of novel drug candidates that address oncology and hematology indications. President and CEO Spiro Rombotis joined the company as its […]